Search

Fagron

Uždarymo kaina

SektoriusSveikatos priežiūra

20.7 -0.24

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

20.5

Max

20.85

Pagrindiniai rodikliai

By Trading Economics

Pajamos

5.4M

46M

Pardavimai

34M

476M

P/E

Sektoriaus vid.

17.778

36.442

Dividendų pajamingumas

1.67

Pelno marža

9.569

Darbuotojai

3,989

EBITDA

16M

87M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+20.59% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.67%

3.00%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

86M

1.5B

Ankstesnė atidarymo kaina

20.94

Ankstesnė uždarymo kaina

20.7

Naujienos nuotaikos

By Acuity

50%

50%

166 / 371 reitingas Healthcare

Fagron Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-14 22:33; UTC

Uždarbis

America Movil 3Q Profit Jumps on Higher Revenue, Lower Financial Costs

2025-10-14 22:21; UTC

Pagrindinės rinkos jėgos

Dentsply Sirona Shares Rise After SEC Probe Ends

2025-10-14 19:27; UTC

Įsigijimai, susijungimai, perėmimai

Bouygues Telecom, Free-iliad, Orange Offer to Buy Most Altice French Assets for About $20 Billion

2025-10-14 17:56; UTC

Pagrindinės rinkos jėgos

Nova Minerals Surges; Will Provide Minerals Briefing to Australian Government Ahead of Trump Meeting

2025-10-14 23:38; UTC

Rinkos pokalbiai

Nikkei May Rise Amid Possible Bargain-Hunting -- Market Talk

2025-10-14 22:12; UTC

Rinkos pokalbiai
Uždarbis

Fletcher Building's 1H Earnings Likely Down 16% -- Market Talk

2025-10-14 21:40; UTC

Uždarbis

America Movil 3Q EBITDA MXN93.82B, Up 4.9% on Year >AMX.MX

2025-10-14 21:39; UTC

Uždarbis

America Movil 3Q Rev MXN232.92B, Up 4.2% on Year >AMX.MX

2025-10-14 21:38; UTC

Uždarbis

America Movil 3Q Net MXN22.7B Vs. Net MXN6.43B Year Ago >AMX.MX

2025-10-14 21:06; UTC

Uždarbis

These Stocks Moved the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More -- Barrons.com

2025-10-14 20:50; UTC

Rinkos pokalbiai
Uždarbis

Financial Services Roundup: Market Talk

2025-10-14 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-10-14 20:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-10-14 20:50; UTC

Rinkos pokalbiai
Uždarbis

Health Care Roundup: Market Talk

2025-10-14 20:13; UTC

Uždarbis

BlackRock's Assets Hit Record $13.5 Trillion After Market Rally, Dealmaking Spree -- 2nd Update

2025-10-14 20:01; UTC

Uždarbis

Goldman Sachs Profit Surges, Fueled by Dealmaking Boom -- 5th Update

2025-10-14 19:21; UTC

Rinkos pokalbiai
Uždarbis

Citigroup's Higher Outlook Leaves Questions -- Market Talk

2025-10-14 19:12; UTC

Įsigijimai, susijungimai, perėmimai

Bouygues Telecom, Free-iliad, Orange Offer to Buy Most Altice French Assets for About $20B

2025-10-14 19:08; UTC

Rinkos pokalbiai

Oil Futures Settle Lower on Trade, Oversupply Concerns -- Market Talk

2025-10-14 19:02; UTC

Rinkos pokalbiai

U.S. Natural Gas Falls as Weather Outlook Stays Mild -- Market Talk

2025-10-14 18:59; UTC

Įsigijimai, susijungimai, perėmimai

Bouygues Telecom, Free-iliad Group, Orange Bid for Corresponds to Total Enterprise Value of EUR17B for Altice France Assets

2025-10-14 18:58; UTC

Įsigijimai, susijungimai, perėmimai

Bouygues Telecom, Free-iliad Group, Orange Bid Excludes Stakes in Intelcia, UltraEdge, XP Fibre, Altice Technical Services

2025-10-14 18:58; UTC

Įsigijimai, susijungimai, perėmimai

Bouygues Telecom, Free-iliad Group, Orange Bid Covers Most SFR Assets

2025-10-14 18:56; UTC

Įsigijimai, susijungimai, perėmimai

Bouygues Telecom, Free-iliad Group, Orange Submit Joint Non-Binding Offer to Buy Large Part of Altice's Activities in France

2025-10-14 18:46; UTC

Uždarbis

These Stocks Are Moving the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More -- Barrons.com

2025-10-14 18:04; UTC

Uždarbis

Goldman Sachs Profit Surges, Fueled by Dealmaking Boom -- 4th Update

2025-10-14 18:01; UTC

Rinkos pokalbiai

Gold Finds Another Record as Traders Eye Further Upside -- Market Talk

2025-10-14 17:54; UTC

Uždarbis

Salesforce's Dreamforce Conference Kicks Off. CEO Benioff Touts AI Tool Agentforce. -- Barrons.com

2025-10-14 17:50; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-10-14 17:50; UTC

Rinkos pokalbiai

Lower Dollar Provides Some Strength in Grains -- Market Talk

Fagron Prognozė

Kainos tikslas

By TipRanks

20.59% į viršų

12 mėnesių prognozė

Vidutinis 19.5 EUR  20.59%

Aukščiausias 19.5 EUR

Žemiausias 19.5 EUR

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Fagron kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

1

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

166 / 371 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Fagron

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.
help-icon Live chat